Cadmium is a toxic heavy metal you have been quietly collecting since childhood. It enters your body through food (especially rice, shellfish, organ meats, and leafy greens), tobacco smoke, and contaminated air, and once inside it sticks around for 10 to 40 years. Your kidneys and liver hold onto it, slowly accumulating a burden that standard cholesterol panels, kidney panels, and CBCs will not detect until late.
A 24-hour urine collection captures the small fraction of stored cadmium your body releases each day, giving you a stable read on how much has built up over your lifetime. Higher numbers track with greater risk of kidney damage, bone loss, cardiovascular disease, lung cancer, and earlier death, often at levels well below older safety thresholds.
The lab quantifies the total micrograms of cadmium your kidneys cleared into urine across a full 24 hours. Because only a tiny fraction of stored cadmium is excreted daily, this number is treated as a fingerprint of long-term body burden, not recent intake. Blood cadmium, by contrast, reflects exposure in the past few months and rises sharply with recent smoking or contaminated meals.
Once inside your bloodstream, cadmium binds to a small carrier protein called metallothionein and travels mainly to the kidney cortex and liver. The kidney filters this complex, reabsorbs much of it, and releases a small amount into urine. In people with significant kidney damage, urinary cadmium can also reflect injury-driven leakage from damaged tubules, not just stored cadmium, so context matters.
Your kidneys are cadmium's primary target. The metal accumulates in proximal tubules (the part of the kidney that reclaims useful proteins and minerals from urine) and slowly impairs their function. Damage often begins long before serum creatinine or eGFR move.
Population data consistently link higher urinary cadmium with early tubular injury markers like α1-microglobulin, KIM-1, and NAG, even in adults with normal routine kidney panels. In a Chinese study of 1,235 adults with low environmental exposure, tubular markers rose at cadmium levels comparable to typical US reference values. Pooled analyses across populations find that current environmental exposure in industrialized countries is enough to raise chronic kidney disease risk.
Risk is amplified if you already have diabetes or hypertension. In US NHANES data covering 12,577 adults, the inverse association between cadmium and eGFR was strongest in women and in people with diabetes or high blood pressure. In a Spanish general-population study of 1,397 adults, higher urinary cadmium was strongly tied to albuminuria, even among people without diabetes, hypertension, or known kidney disease.
Cadmium is classified as a known human carcinogen. In a prospective Belgian study of 994 adults followed for years, a doubling of 24-hour urinary cadmium was tied to roughly 31% higher overall cancer risk (HR 1.31) and 70% higher lung cancer risk (HR 1.70). Living near a smelter or growing food in cadmium-contaminated soil pushed lung cancer risk higher still.
In a separate study of former smokers, those in the highest cadmium quartile had markedly higher odds of lung cancer, including early-stage disease, suggesting urinary cadmium can flag people who would benefit from aggressive lung cancer screening with low-dose CT. Associations with breast cancer in pooled meta-analyses are weaker and less consistent when urinary cadmium is the exposure measure.
Higher urinary cadmium tracks with more atherosclerosis, coronary heart disease, heart failure, and stroke. A 2024 dose-response meta-analysis of urinary and blood cadmium studies found that cardiovascular risk rises with urinary cadmium up to about 0.5 µg/g creatinine, then plateaus. In the Multi-Ethnic Study of Atherosclerosis (MESA), which followed 6,599 US adults, higher urinary cadmium was associated with both incident cardiovascular events and all-cause mortality.
In a separate cohort of 11,193 adults, low-level cadmium exposure was linked to mortality partly through worsening subclinical heart muscle injury and hemodynamic stress, as measured by troponin and NT-proBNP (a blood marker of heart strain). Cadmium also raises blood pressure: a 2024 meta-analysis found a linear positive association between urinary cadmium and hypertension risk.
Cadmium displaces calcium and damages the cells that build bone. In a prospective cohort of 4,024 women followed long-term, dietary cadmium exposure was linked to higher risks of fractures and all-cause mortality at lower levels than older guidelines had suggested. Modeling of US adults aged 50 to 79 estimated that about 16% of osteoporosis cases in this group could be attributed to cadmium exposure, with risk rising linearly across the population's exposure range.
In the original Belgian environmental cohort of 956 adults, a doubling of 24-hour urinary cadmium predicted higher total and non-cardiovascular mortality, with risk rising continuously and no clear safe threshold. A 2016 meta-analysis of cohort studies confirmed that even low-level urinary cadmium is tied to higher all-cause, cancer, and cardiovascular mortality in the general population.
In a NHANES analysis of 1,083 adults, higher urinary cadmium was linked to greater phenotypic age (a composite blood-based aging score), and the metal mediated much of smoking's effect on accelerated aging. Among adults with diabetes or prediabetes (17,687 people), cadmium exposure raised the risk of all-cause, cardiovascular, and cancer mortality, with oxidative stress and inflammation partially mediating the effect.
There is no universally adopted clinical cutpoint for 24-hour urinary cadmium in healthy adults. Most outcome studies report results in µg/g creatinine (a way of correcting for how dilute or concentrated the urine is), while this test reports total µg per 24 hours. The ranges below are research-derived orientation, not diagnostic thresholds, and your lab may use slightly different cutpoints.
| Tier | Approximate Range | What It Suggests |
|---|---|---|
| Low background | Below 1 µg/24 hr | Typical for non-smokers in industrialized countries with limited dietary exposure |
| Elevated environmental | 1 to 2 µg/24 hr (or roughly 0.5 to 1 µg/g creatinine) | Associated with rising risk of early kidney tubular injury and cardiovascular disease in population studies |
| High burden | Above 2 µg/24 hr (or roughly above 2 µg/g creatinine) | Consistently linked to overt tubular dysfunction, bone demineralization, and CKD in environmentally and occupationally exposed groups |
Sources: ranges synthesized from Nawrot 2006/2008 (Belgian Cadmibel cohort, n=994 and 956), Qing 2021 (Chinese residents), and Satarug 2022 (NOAEL-equivalent analysis). Compare your results within the same lab over time for the most meaningful trend, since assays and matrices vary.
Urinary cadmium is one of the most temporally stable biomarkers in environmental medicine. Studies measuring the same people years apart find intraclass correlations of 0.66 to 0.90 (where 1.0 would be a perfect match), meaning a single 24-hour result gives you a reasonable read on long-term exposure. In one analysis of older adults whose urines were collected 4 to 6 years apart, the correlation was 0.85.
That said, intra-individual variability is not zero. In occupationally exposed workers, the coefficient of variation across creatinine-corrected samples within a week was about 18%, meaning a single result can wander by roughly that much for reasons unrelated to your true burden. To rank yourself confidently against population data, two measurements a few months apart are better than one. After that, annual retesting tracks whether your exposure is rising, holding steady, or falling with intervention.
An elevated 24-hour urinary cadmium is not a diagnosis, it is a signal to investigate further and reduce exposure. The next workup typically combines a kidney panel (creatinine, cystatin C, eGFR, urine albumin-to-creatinine ratio), tubular injury markers if available (such as α1-microglobulin or KIM-1), and a careful review of dietary sources and smoking history. People with elevated cadmium plus rising albuminuria or falling eGFR should consider a nephrology consult, particularly if other risk factors like diabetes or hypertension are present.
Former and current smokers with elevated results, especially those over 50, deserve a conversation about low-dose CT lung cancer screening, since cadmium adds independent risk on top of smoking history. There is no proven, safe drug to remove cadmium from the body, so the primary intervention is to identify and reduce ongoing exposure (described in the interventions section) while monitoring kidney and cardiovascular markers over time.
Evidence-backed interventions that affect your Cadmium 24 Hour level
Cadmium 24 Hour is best interpreted alongside these tests.